Paul A. Friedman, Director at MADRIGAL PHARMACEUTICALS, INC. (MDGL), sold 2,800 shares at $350.03 ($980K) on 2025-07-18, disclosed to the SEC on 2025-07-22.
Scheduled sale ($980k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $350.03 | 1,400 | $490K | 50.0% |
| 2 | $350.03 | 1,400 | $490K | 50.0% |
| Total | $350.03 avg | 2,800 | $980K | 100% |
| Filing → |
| MDGL | SELL | 2025-12-12 | $26.5M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $30.6M | — | Filing → |
| MDGL | SELL | 2025-08-13 | $95.1M | — | Filing → |